Literature DB >> 9196963

Influenza and influenza-like illness in general practice: drawing lessons for surveillance from a pilot study in Paris, France.

F Carrat1, A Tachet, B Housset, A J Valleron, C Rouzioux.   

Abstract

BACKGROUND: There are two types of inflenza surveillance techniques: qualitative laboratory-based surveillance and quantitative medical practice-based surveillance. The former is of great importance in isolating new strains of the virus, which helps in the decision-making process concerning the composition of the vaccine, and the latter provides estimates of morbidity, mortality or economic impact as a result of infection from the influenza virus. Rapid methods such as immunoflourescence (IF) or immunocapture assays (ICA) are now available for diagnosis of influenza infections. However, little is known about the use of these methods for influenza surveillance purposes. AIMS: To evaluate the feasibility of a rapid influenza diagnosis in ambulatory conditions, and to investigate the therapeutical outcomes of patients suffering from influenza-like illness (ILI) in relation to the virological diagnoses.
METHOD: During the 1994-1995 influenza season, 130 patients presenting with ILI symptoms (< 36 hours) to 33 general practitioners (GPs) were included in a prospective study. Two nasal swabs and one throat swab per patient were collected and sent to the laboratory within 12 hours. Information concerning therapeutical outcomes was recorded during examination. Specimens were analysed using the immunofluorescence (IF) method and antigen immunocapture assay (ICA).
RESULTS: Sixteen influenza A (12%) and 19 influenza B (15%) infections were diagnosed. The overall rate of influenza positive specimens was 17% in the pre-epidemic period and 31% during the epidemic (P = 0.1). The rates of usable specimens for IF assay, nasal ICA and throat ICA were 46%, 100% and 99% respectively. The combination of these three collections ensured a highly sensitive influenza virological diagnosis. There were no differences in therapeutical outcomes between the influenza positive and negative cases. The GPs prescribed antibiotics in 60% of the cases for a mean duration of 7 days (+/- 1.2). The mean duration of sick leave was 3.4 days (+/- 1.6). Twelve patients (four influenza positive, eight influenza negative) had been vaccinated at the beginning of the winter. The practitioner's intuition concerning 'which patient should be tested for influenza virus' did not prove useful in improving the aptness of virological diagnoses in the field of influenza surveillance.
CONCLUSION: The only way to estimate the true impact of influenza is to carry out a systematic virological sampling based on a sensitive clinical definition and using sensitive laboratory methods.

Entities:  

Mesh:

Year:  1997        PMID: 9196963      PMCID: PMC1312945     

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  16 in total

1.  Eurosentinel: development of an international sentinel network of general practitioners.

Authors:  V van Casteren; P Leurquin
Journal:  Methods Inf Med       Date:  1992-06       Impact factor: 2.176

2.  Direct detection of influenza virus antigen in nasopharyngeal specimens by direct enzyme immunoassay in comparison with quantitating virus shedding.

Authors:  G Döller; W Schuy; K Y Tjhen; B Stekeler; H J Gerth
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

3.  A routine tool for detection and assessment of epidemics of influenza-like syndromes in France.

Authors:  D Costagliola; A Flahault; D Galinec; P Garnerin; J Menares; A J Valleron
Journal:  Am J Public Health       Date:  1991-01       Impact factor: 9.308

4.  Combined clinical and virological surveillance of influenza in winters of 1992 and 1993-4.

Authors:  D M Fleming; P Chakraverty; C Sadler; P Litton
Journal:  BMJ       Date:  1995-07-29

5.  Influenza: global surveillance for epidemic and pandemic variants.

Authors:  N J Cox; T L Brammer; H L Regnery
Journal:  Eur J Epidemiol       Date:  1994-08       Impact factor: 8.082

6.  Rapid diagnosis of influenza infection of NP antigen using an immunocapture ELISA test.

Authors:  J J Chomel; D Thouvenot; M Onno; C Kaiser; J M Gourreau; M Aymard
Journal:  J Virol Methods       Date:  1989-07       Impact factor: 2.014

Review 7.  Studies of the community and family: acute respiratory illness and infection.

Authors:  A S Monto
Journal:  Epidemiol Rev       Date:  1994       Impact factor: 6.222

8.  Acute respiratory illness in the community. Frequency of illness and the agents involved.

Authors:  A S Monto; K M Sullivan
Journal:  Epidemiol Infect       Date:  1993-02       Impact factor: 2.451

9.  [Anti-influenza vaccination for active persons (25-64 years): a cost-benefit study].

Authors:  E Levy; P Levy
Journal:  Rev Epidemiol Sante Publique       Date:  1992       Impact factor: 1.019

10.  Medical practice-based influenza surveillance: viral prevalence and assessment of morbidity.

Authors:  A S Monto; S E Ohmit; J R Margulies; A Talsma
Journal:  Am J Epidemiol       Date:  1995-03-15       Impact factor: 4.897

View more
  5 in total

1.  Comparison of four clinical specimen types for detection of influenza A and B viruses by optical immunoassay (FLU OIA test) and cell culture methods.

Authors:  K A Covalciuc; K H Webb; C A Carlson
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

2.  Clinical diagnosis of influenza virus infection: evaluation of diagnostic tools in general practice.

Authors:  L J van Elden; G A van Essen; C A Boucher; A M van Loon; M Nijhuis; P Schipper; T J Verheij; I M Hoepelman
Journal:  Br J Gen Pract       Date:  2001-08       Impact factor: 5.386

Review 3.  A flu optical immunoassay (ThermoBioStar's FLU OIA): a diagnostic tool for improved influenza management.

Authors:  S P Tucker; C Cox; J Steaffens
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-12-29       Impact factor: 6.237

4.  Impact of influenza treatment with oseltamivir on health, sleep and daily activities of otherwise healthy adults and adolescents.

Authors:  Robert Bettis; Dominick Iacuzio; Thomas Jung; Rudolf Fuchs; Rick Aultman; Marlene Gyldmark
Journal:  Clin Drug Investig       Date:  2006       Impact factor: 2.859

5.  Influenza testing, diagnosis, and treatment in the emergency department in 2009-2010 and 2010-2011.

Authors:  Timothy R Peters; Cynthia K Suerken; Beverly M Snively; James E Winslow; Milan D Nadkarni; Scott B Kribbs; Katherine A Poehling
Journal:  Acad Emerg Med       Date:  2013-08       Impact factor: 3.451

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.